Agazym

N/A

Report date: 2025/01/26 16:05:12
NME

Base Information

Drug NameAgazym
Drug Alias NameEnzyme replacement therapy candidates (Chiesi Farmaceutici)ERT candidate (Chiesi Farmaceutici)ZA-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZymenex As
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesZymenex As
Active IndicationsLysosomal Storage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A